Lindsay Stoops
Family Medicine · Spring, TXNPI 1912580051
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 81 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Novo Nordisk at 27.4% of the total. 2025 is the largest year on record at $1,462, more than ten times the $44 reported in 2022.
Across 81 payments — averaging $24.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$534
- Amgen$281
- AstraZeneca$240
- Medtronic$193
- GSK$185
- AbbVie$86
- plus $430 from 13 others
What the payments were for
- Food & beverage$1,949100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 20 | $534 |
| Amgen(2 entities) | 12 | $281 |
| AstraZeneca(2 entities) | 11 | $240 |
| Medtronic | 3 | $193 |
| GSK | 10 | $185 |
| AbbVie | 4 | $86 |
| Inspire Medical Systems, Inc. | 2 | $46 |
| UCB, Inc. | 2 | $46 |
| Merck | 2 | $43 |
| Organon | 3 | $40 |
| Corcept Therapeutics | 2 | $40 |
| Dexcom, Inc. | 2 | $37 |
| Lilly USA, LLC | 2 | $32 |
| Indivior Inc. | 1 | $30 |
| Kyowa Kirin, Inc. | 1 | $29 |
| Dynavax Technologies Corporation | 1 | $29 |
| Exact Sciences | 1 | $28 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,949 in reported general payments places this provider in the 70th percentile of 8,760 family medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $3,253 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 18 | $645 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 18 | $587 |
| Omeprazole | 21 | $443 |
| Duloxetine Hcl | 26 | $419 |
| Atenolol-ChlorthalidoneAtenolol/Chlorthalidone | 14 | $360 |
| Gabapentin | 34 | $359 |
| Atorvastatin Calcium | 46 | $329 |
| Fluticasone Propionate | 16 | $321 |
| Amlodipine Besylate | 22 | $284 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 12 | $279 |
| Lisinopril | 47 | $245 |
| Levothyroxine Sodium | 38 | $205 |
| Montelukast Sodium | 19 | $169 |
| Pantoprazole Sodium | 21 | $145 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Spring
- Carlos CamposNew Braunfels$1.5M
- Aaron KingSan Antonio$1.1M
- Bradley WassonArlington$734K
- Cynthia BrinsonAustin$402K
- Michael MendezLubbock$368K
- Sang Tae KimAmarillo$368K
- Sumit PerakathuHarlingen$342K
- Joel SolisMcAllen$324K
- Robert CampbellFort Worth$318K
- Jose LedezmaEdinburg$300K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.